— Signal history
OTLK alerts
Every time Stock Pulse flagged OTLK in real time — with the full post-mortem behind each alert.
1alert
+3%best run
+3%median peak
-38%worst close
Healthcare · Biotechnology
Outlook Therapeutics, Inc.
Outlook Therapeutics is a biotech developing ONS-5010/LYTENAVA, a bevacizumab formulation for wet AMD.
Cap~$108M / float: 83M
Day volume~346M (~67x avg)
Prev close$0.3099 → premarket high $0.725 at 7:42 AM, up 134%
52w range$0.16–$3.39
Snapshot from the May 26, 2026 post-mortem.
